GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » S2Medical AB (FRA:S21) » Definitions » COGS-to-Revenue

S2Medical AB (FRA:S21) COGS-to-Revenue : 0.05 (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is S2Medical AB COGS-to-Revenue?

S2Medical AB's Cost of Goods Sold for the three months ended in Jun. 2024 was €0.01 Mil. Its Revenue for the three months ended in Jun. 2024 was €0.26 Mil.

S2Medical AB's COGS to Revenue for the three months ended in Jun. 2024 was 0.05.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. S2Medical AB's Gross Margin % for the three months ended in Jun. 2024 was 94.62%.


S2Medical AB COGS-to-Revenue Historical Data

The historical data trend for S2Medical AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

S2Medical AB COGS-to-Revenue Chart

S2Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial -0.26 0.61 0.08 -0.11 0.28

S2Medical AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.76 -0.25 0.55 -0.01 0.05

S2Medical AB COGS-to-Revenue Calculation

S2Medical AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.173 / 0.623
=0.28

S2Medical AB's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.014 / 0.26
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


S2Medical AB  (FRA:S21) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

S2Medical AB's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.014 / 0.26
=94.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


S2Medical AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of S2Medical AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


S2Medical AB Business Description

Traded in Other Exchanges
Address
Sunnorpsgatan 5, Linkoping, SWE, 582 73
S2Medical AB is a research-intensive MedTech company from Sweden. The company has developed several unique wound care products and has many disruptive technologies in the pipeline. Its products include wound debridment, blood stilling, skin grafting, tissue substitutes, bandage, and antimicrobial.

S2Medical AB Headlines

No Headlines